Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Press Release

With Alzheimer’s treatment stalled, promising pipeline drugs and a shift in perception could be key to tackling the disease, says GlobalData

As World Alzheimer’s Day approaches (21 September) with the aim of raising global awareness and understanding of the issues faced by people affected by dementia it’s timely to reflect that no new drug for Alzheimer’s disease (AD) has been approved in the past 16 years, despite more than 400 clinical trials and billions of dollars […]
Read more

Number of respiratory conditions will continue to rise if UK air pollution goes unchecked, says GlobalData

The number of people suffering from respiratory indications and the severity of those already suffering from the various diseases is expected to increase if air pollution in the UK goes unchecked, says GlobalData, a leading data and analytics company. According to GlobalData’s reports: ‘PharmaPoint: Asthma’ states that the prevalence of asthma in the UK hovers […]
Read more

Regeneron’s supplemental biologics license application of Eylea for the treatment of diabetic retinopathy could slow its downfall, says GlobalData

Following Regeneron’s announcement that the FDA has accepted to review a supplemental biologics license application (sBLA) of Eylea for the treatment of diabetic retinopathy, Edit Kovalcsik, Managing Analyst at GlobalData, a leading data and analytics company, offers her view on the impact of this indication expansion on the Eylea market; “Regeneron’s Eylea (aflibercept), a vascular […]
Read more

Lactalis’s acquisition of Aspen’s infant formula division boosts its potential in Chinese market, says GlobalData

Following Lactalis’s €740m (US$860.1m) purchase of South African-based pharma giant Aspen’s infant formula division, Fiona Dyer, Consumer Analyst at GlobalData, a leading data and analytics company, offers her view: “After baby milk brands were tainted by a salmonella infection scandal earlier in the year, Lactalis is seeking to win over several-times-bitten Chinese consumers by acquiring […]
Read more

Approval of Keytruda in Europe for first-line use with chemotherapy in lung cancer strengthens the use of PD-1 inhibitors as backbone therapy, says GlobalData

Following FDA approval in August, this week (wk comm 10th Sept) the European Commission (EC) also approved Merck Sharp & Dohme (MSD)’s PD-1 blocking antibody, Keytruda (pembrolizumab), for use as a first-line therapy in combination with Eli Lilly’s Alimta (pemetrexed) plus platinum chemotherapy, for patients with metastatic non-small cell lung cancer (NSCLC) who have no […]
Read more

Oil & Gas, Metals & Mining, and construction are top performers in latest business sector performance analysis 2017, researched by GlobalData

In its latest research, leading data and analytics company GlobalData analyzed the total revenue and profit change of 10 core business sectors that it tracks, based on the performance of the top 25 publicly traded companies in each sector (2017 vs. 2016). Of the 10 sectors, oil & gas, metals & mining, and construction emerged […]
Read more

Over a quarter of consumers influenced by local gastronomy in their holiday destination choice, says GlobalData

Globalization, coupled with a shift in cultural and economic influence from West to East and the boom in travel flows around the world, is resulting in consumers becoming increasingly familiar with and enthusiastic about different food cultures, according to GlobalData a leading data and analytics company. GlobalData’s latest consumer survey for Q3-2018, reveals that 27.6% […]
Read more

The sky is the limit for Novartis’ CAR-T therapy Kymriah after approval for NHS use in paediatric leukemia patients, says GlobalData

Following the announcement that the NHS have accepted the revolutionary new Novartis CAR-T therapy, Kymriah, for children with leukemia, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on how this will impact the oncology market: “There is significant hype behind this therapy, as it offers a personalised approach […]
Read more
1 … 44 45 46 47 48 … 61